A role of human beta defensin-1 in predicting prostatic adenocarcinoma in cases of false-negative biopsy
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2016R1D1A1A09919609)
This publication has 31 references indexed in Scilit:
- Markers of Field Cancerization: Proposed Clinical Applications in Prostate BiopsiesProstate Cancer, 2012
- Risk Factors for Prostate Cancer Detection After a Negative Biopsy: A Novel Multivariable Longitudinal ApproachJournal of Clinical Oncology, 2010
- Evidence for field cancerization of the prostateThe Prostate, 2009
- PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancerMolecular Immunology, 2009
- Functional analysis of the host defense peptide Human Beta Defensin-1: New insight into its potential role in cancerMolecular Immunology, 2008
- Human β-Defensin-1, a Potential Chromosome 8p Tumor Suppressor: Control of Transcription and Induction of Apoptosis in Renal Cell CarcinomaCancer Research, 2006
- Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies?International Journal of Urology, 2006
- Antimicrobial peptides of multicellular organismsNature, 2002
- β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6Science, 1999
- Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.Journal of Clinical Investigation, 1998